All posts by imreal

NeoTract Designates Dr. Christopher Girasole as UroLift® Center of Excellence


News Image

“Dr. Christopher Girasole has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Christopher Girasole, M.D., Manchester Urology Associates in Manchester, NH, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Girasole has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Christopher Girasole has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Mercury Insurance Extends Identity Fraud Resolution Services Coverage to Include Relatives Outside of the Insured Residence


This coverage helps with the recovery process if identity fraud is detected, giving our customers and their families one less thing to worry about during these uncertain times.

Today, Mercury Insurance (NYSE: MCY) announced that, until August 31, 2020, it has temporarily extended Resolution Services coverage for its “Identity Fraud Expense and Resolution Services” customers to include their relatives who don’t live in the insured residence. This coverage, which is available to Mercury homeowners and renters policyholders, helps customers recover from account takeover or identity theft.

The IRS extended this year’s tax filing to July 15, 2020, to reduce the COVID-19 pandemic outbreak’s impact on taxpayers. While this extension offers some much-needed relief to those who may be struggling financially, it also lengthens the window in which criminals are able to target unsuspecting individuals with a variety of scams in an attempt to steal their identity, as well as refunds that may be coming their way.

“Criminals have many ways they can try to steal someone’s identity – most people have multiple online accounts, as well as electronic devices like smartphones, PCs and tablets, which makes them more vulnerable to scams than ever before,” said Jane Li, Mercury Insurance director of product development. “This coverage helps with the recovery process if identity fraud is detected, giving our customers and their families one less thing to worry about during these uncertain times.”

Each year, the IRS publishes its “Dirty Dozen” list of tax scams of which taxpayers need to be aware. The 2019 list includes the following schemes taxpayers may fall victim to: phishing, phone scams, identity theft, return preparer fraud, inflated refund claims, falsifying income to credit claims and fake charities.

Mercury’s Identity Fraud Expense and Resolution Services coverage provides support for a variety of events, including but not limited to:

  • Tax Identity Theft Support: Experts provide guidance to secure the insured’s tax refund if their social security number was stolen and someone falsely files taxes in their name.
  • Email Identity Support: Protects against email hacking, as well as helps the insured manage their identity and privacy in online communications.
  • Phish Assist: Detects attempts to steal the insured’s personal data, online usernames, passwords and credit card data, and provides recovery support if needed.
  • Document Replacement Services: Helps the insured replace lost, stolen or destroyed identification documents, and notify government agencies and providers of the fraud.
  • Resolution Services: Offers unlimited assistance from a fraud resolution specialist to fix issues, handle notifications, and provide credit and fraud monitoring to help the insured recover from account takeover or identity theft. This coverage is temporarily available until August 31, 2020, for the insured’s family members who live outside of the household.

Mercury’s Identity Fraud Expense and Resolution Services is optional coverage, which is available for less than $3 a month and provides up to $25,000 for expenses that might be incurred if the insured’s identity is stolen, including lost income, notary and attorney fees, mailing costs and loan application fees. Homeowners and renters in Arizona, California, Georgia, Illinois, Nevada, New Jersey, Oklahoma, Texas and Virginia can add this coverage to their policy. Go to https://www.mercuryinsurance.com/insurance/identity-management-services/ or contact a local Mercury Insurance agent to learn more.

Additional ways Mercury has shown support during the COVID-19 pandemic include the Mercury Customer Giveback Program and its new partnership with the California Medical Association’s Care 4 Caregivers Now wellness program for healthcare workers.

About Mercury Insurance

Mercury Insurance (MCY) is a multiple-line insurance organization predominantly offering personal automobile, homeowners and business insurance through a network of independent agents in Arizona, California, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas and Virginia. Since 1962, Mercury has specialized in offering quality insurance at affordable prices. For more information, visit http://www.mercuryinsurance.com or Facebook and follow the company on Twitter.

Share article on social media or email:

Office Furniture Direct (OFD) Prepares Local Business for Post-Pandemic Re-Openings


At OFD, we feel an obligation to help businesses prepare for the “New Normal” and help them navigate this challenging, but necessary, evolution of the workplace.

OFD | Office Furniture Direct, Long Island’s largest office furniture source, has announced a line of solutions that will help businesses create safe

environments for their employees and clients alike. The move was made to meet State standards, as well as applicable federal requirements, while also creating a sense of security, safety and style in the workplace.

“Business owners across the Metro Area and beyond are faced with challenges of reconfiguring their office environments to adhere with State-mandated rules for social distancing,” said OFD partner Kamron Monasebian. “These solutions will help companies maintain distancing in the office without sacrificing form, function or collaboration.”

Glass screens, Acrylic dividers and mobile screens are just some of the products immediately available to help companies achieve distancing by incorporating protective barriers to help prevent the spread of germs.

“At OFD, we feel an obligation to help businesses prepare for the “New Normal” and help them navigate this challenging, but necessary, evolution of the workplace,” said Monasebian. “It’s not just vital to the health of employees and businesses; it’s vital to the health of the communities we serve.

For more on OFD’s social distancing and wellness solutions, contact OFD at: 631.777.2027, or visit: https://www.ofdonline.com/social-distancing-wellness-solutions.html.

MORE ABOUT OFD

Office Furniture Direct is Long Island’s largest office furniture source, where optimal function and ergonomics meet extraordinary comfort and style. Specializing in workplace furniture solutions, the OFD team assists from initial design to product selection through installation and beyond.

Share article on social media or email:

Eighth Circuit Affirms $34.3M Jury Verdict Against State Farm Life Insurance Co.


“The court’s decision affirms that, simply put – if you want to charge for it, you need to put it in the contract.”

The class action was filed in June 2016, in the Western District of Missouri by Michael Vogt and other individuals who owned universal life insurance policy form 94030 issued by State Farm. The lawsuit alleged that State Farm breached the terms of the policies by overcharging policyholders through cost of insurance provisions causing policies to lose value and in many cases lapse, leaving many without life insurance.

Trial commenced June 1, 2018 and the jury awarded $34.3 million to approximately 24,000 Missouri policyholders. State Farm appealed to the Eighth Circuit asserting various errors and Vogt cross appealed. Vogt prevailed on all issues.

“We’re very happy with the court’s decision to affirm the trial court,” said John Schirger, co-lead counsel and founding partner of Miller Schirger LLC. “We hope that these policyholders, who for decades were unknowingly overcharged, will soon finally receive payments.”

“Many insurers define the cost of their insurance fees by delineating factors outside typically considered mortality elements and in this case the costs of charges weren’t outlined with specificity,” said Norman Siegel, co-lead counsel and founding partner of Stueve Siegel Hanson LLP. “The court’s decision affirms that, simply put – if you want to charge for it, you need to put it in the contract.”

Stueve Siegel Hanson LLP and Miller Schirger LLC are currently representing clients in similar cases in California, Texas and the State of Washington, and are investigating matters involving life insurance policies nationwide. The firms have a successful record prosecuting class action cases alleging policy overcharges against the life insurance industry, having collected over $2.25 billion in client value over the last five years against some of the nation’s largest life insurance companies.

Stueve Siegel Hanson LLP is a Kansas City, Missouri based firm representing businesses and individuals in high-stakes litigation nationwide on a contingency basis. The firm is one of the preeminent plaintiff’s trial law firms in the nation, known for its high-stakes, landmark verdicts and settlements in significant individual and class action litigation. Since its establishment in 2001, the firm has led some of the most complex and high-profile cases in state and federal courts, recovering billions in verdicts and settlements. For more information visit http://www.stuevesiegel.com.

Miller Schirger LLC is a Kansas City, Missouri based law firm focused on resolving complex disputes on behalf of businesses and individuals nationwide. The firm has a proven track record of success representing plaintiffs and defendants in state and federal trial and appellate courts. For over ten years the firm’s class action practice has been focused on prosecuting claims against the life insurance industry, resulting in the recovery of over $2.25 billion in client value. For more information visit http://www.millerschirger.com.

Vogt v. State Farm Life Insurance Co., No. 18-3419 (8th Cir. 2020)

Share article on social media or email:

How Unemployed Drivers Can Save Money on Auto Insurance


News Image

“The best way to find affordable car insurance while being unemployed is by comparing online quotes from insurance providers that are available in the area.”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Compare-autoinsurance.org has launched a new blog post that presents several measures unemployed drivers can take to get cheaper car insurance.

For more info and free car insurance quotes, visit https://compare-autoinsurance.org/how-to-find-cheaper-car-insurance-after-losing-your-job/

The current coronavirus outbreak has caused millions to lose their jobs. Many people are struggling to pay their rent and utilities, even though they have no income or they have to rely on an unemployment check. Car insurance might be one place where many can reduce their expenses.

Unemployed drivers who are looking to save money on car insurance should do the following:


  • Contact the insurance provider. Many car insurance companies are offering discounts, refunds, bill payment flexibility, and other options as many drivers are struggling in these challenging times. Although most companies had resumed normal billing by the end of May 2020, they are still ready to help customers who are going through difficulties. The best solution for unemployed drivers is to contact them directly and let them know about their job status.
  • Check the current policy. Keeping full coverage on an older vehicle while being unemployed is just a waste of money and unemployed drivers should avoid doing so at least until they get a new job. Raising the deductible to pay lower premiums is another great move drivers can make to save some money on car insurance. Most unemployed drivers are no longer required to make a commute and they have a reduced driving risk. For this reason, they should contact their insurers and ask for a low-mileage discount.
  • Be safe on the road. While being unemployed, drivers should avoid getting a DUI, speeding ticket, or a moving violation on their driving records. By doing so, drivers will keep their premiums low.
  • Maintain a good credit score. Not paying bills on time can backfire. The credit score is a major factor in how the rates are set in every state but California, Hawaii, and Massachusetts. Drivers with poor credit can pay nearly twice as much for the same policy as someone with excellent credit.
  • Shop around. Don’t pick the first option that looks good. Unemployed drivers should have plenty of time to check around and compare multiple quotes from different insurance companies.
  • Look for discounts. Unemployed drivers who are also students can get a good student discount if they have good grades in school. Drivers who are moving to a work-from-home career or are driving little should look for providers who are offering pay-per-mile insurance policies. Also, drivers who already have homeowners, renters, condo, life insurance, or other insurance, should think about bundling all household policies with the same company to get a multi-policy discount.
  • Install a telematics device. These policies usually use an under-the-dash plug-in device or smartphone app to check the driving habits. The acceleration, braking, distance, speed, route choice, and time of day can all affect the total savings. Not going back and forth to work five days a week should qualify unemployed drivers for a reduced rate.
  • Apply and pay online for coverage. Buying car insurance on the internet can give the driver a discount. Also, drivers can get a slightly larger discount for electronic payments from their bank account rather than a credit card because of the lack of processing fees. Furthermore, unemployed drivers can save money by paying for the whole policy upfront.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

Share article on social media or email:

BKD Launches Tool to Help Healthcare Providers Track CARES ACT Funding


“BKDTrackForward allows healthcare leaders to streamline and track the funding they receive, allowing them to focus on their mission,” said National Industry Partner Danielle Solomon.

NATIONAL OFFICE – BKD CPAs & Advisors developed and launched a unique tool called BKDTrackForward to help healthcare organization leaders monitor Coronavirus Aid, Relief, and Economic Security Act (CARES Act) Provider Relief Funds.

The CARES Act has provided the healthcare industry with more than $175 billion in relief funding since it was signed into law on March 27, 2020. However, to retain the funding received, it’s anticipated that organizations will be required to provide proof that the funds were used to support healthcare-related expenses or lost revenues attributable to the coronavirus. BKDTrackForward users can track how they spent CARES Act funds, allowing them to be better prepared when regulators ask for documentation.

“Our team understands the uncertainty and complexity healthcare leaders are facing and we are here to be a trusted advisor and assist however we can. BKDTrackForward allows healthcare leaders to streamline and track the funding they receive, allowing them to focus on their mission,” said National Industry Partner Danielle Solomon.

The tool can help users document allowable expenses and labor costs in one place, record the calculation of lost revenues attributable to COVID-19, compare expected CARES Act Provider Relief Funds to amounts received to determine if healthcare leaders have obtained all entitled funds and track Medicare accelerated payments, employer payroll tax deferrals, and a high-level analysis of an organization’s potential to file a business interruption claim as a result of COVID-19.

Visit bkd.com/trackforward for more information and to request a demo.

Share article on social media or email:

Enterprai, an early-stage start-up, to appoint Andrea French, former co-CEO and COO of Rokos Capital, as Interim Chief Executive Officer


Developing a leading product for the industry requires collective intelligence and proven experience in all aspects of building a company

The board of directors of Enterprai will appoint Andrea French, former co-CEO and COO of Rokos Capital Management as well as a former partner and COO of Trading at Brevan Howard, as interim Chief Executive Officer.

Enterprai is an early-stage research and technology start-up building a next-generation smart desktop for investment professionals. The founders are assembling a leadership team of senior executives to ensure the sustainable growth of the organization, which is on a mission to drive the democratisation of quantitative insights in financial markets.

“Developing a leading product for the industry requires collective intelligence and proven experience in all aspects of building a company. We are excited to have Andy on board so early on in our journey. She brings an in-depth understanding of the industry we are looking to serve. The whole team is very much looking forward to working alongside her, and she is already contributing in a number of ways,” commented founders Wojciech Mucha, Tigran Atoyan, and Deyan Ulevinov.

Andy’s deep operational expertise will help the firm navigate the regulatory and commercial considerations of their partners, vendors, and key clients. With a strong track record in key leadership roles across a breadth of organizations, she will help guide the high-caliber team at Enterprai.

The partnership between Enterprai and Andrea is set until the end of 2020. During this time, she will oversee the refinement and execution of Enterprai’s corporate and commercial strategy.

About Enterprai

Enterprai is developing a smart desktop for investment professionals. Born from the ambition of experienced researchers and engineers as well as senior financial market participants, Enterprai Ltd is a London-based start-up on a mission to drive the democratisation of quantitative insights in financial markets.

For more details, visit https://enterprai.com/ and http://www.linkedin.com/company/enterprai

Share article on social media or email:

transcosmos signed partnership agreement with dbE, company with NLP technology used in the pharmaceutical industry


dbE rodanius

dbE rodanius

In addition to the sale of “rodanius for Pharma” to the pharmaceutical industry, transcosmos delivers the solution together with its digital transformation services, thereby solving operational challenges that the industry faces and creating new businesses.

transcosmos inc. hereby announces that the company has signed a partnership agreement with dbE., Inc. (Headquarters: Osaka, Japan). With this new partnership, transcosmos will begin offering “rodanius for Pharma,” their innovative solution designed specifically for the pharmaceutical industry where an extensive amount of visual inspection tasks remain the norm. The solution helps pharmaceutical companies readily detect discrepancies between the master document and a GMP inspection application form, streamline inspection process, and prevent dependency on personal skills and human errors.

About document matching & true-false judgement technologies

“rodanius for Pharma” is a solution that detects writing mistakes, missing or omission of words, and information errors owing to differences in used units and expressions between the two differing types of documents with the use of natural language processing (NLP) technology. A series of master documents developed during drug manufacturing processes in the pharmaceutical industry contain as many as hundreds of pages, and describe the manufacturing process in detail whereas the application form only contains a brief summary of the main points. Due to the huge difference in information volume each document contains, it has been quite a challenge to find errors in the application form with the traditionally available NLP technology.

“rodanius framework,” an analytics platform developed by dbE is equipped with various existing analytics technologies (document vectorization methods: word2vec doc2vec, TF/IDF, LSA, LDA, BERT and more, judgement methods: z-score, sine transformation, regression, random forest, SVM, naive bayes, deep learning and more) as well as dbE’s proprietary AI which is equipped with knowledge to automatically configure the best combination of algorithms for the creation of structured documents, vectorization and judgement according to the data being used. The solution enabled the pharmaceutical companies to suitably combine logics that have not been used traditionally in NLP, and algorithms that are not generally used, thereby conducting an ideal analysis. Ultimately, the solution helped the industry identify any discrepancy in the two different documents that were otherwise difficult owing to the enormous difference in information volume.

dbE has already conducted proof-of-concept (POC) of “rodanius for Pharma” with many major pharmaceutical companies using the companies’ real documents used in their drag manufacturing process. The solution has received high praise for its high level of accuracy that can be fully utilized in their business process. As of today (May 2020), there is no alternative solution to this product in the pharmaceutical industry.

transcosmos and dbE plan to create new industry specific solutions

transcosmos not only sells “rodanius for Pharma” to the pharmaceutical industry but also delivers the solution together with its digital transformation services, thereby solving operational challenges that the industry faces and creating new businesses.

In order to address the changes in, and growing demands for the pharmaceutical industry amid the coronavirus crisis, transcosmos and dbE will offer digital marketing promotions, e-commerce sales and customer support services for consumers.

In partnership with dbE, transcosmos will proactively develop and deliver new services to all industries by making the most of NLP technologies that each company owns. As a first step, the two companies have already kicked off a project to create a solution that auto-generates FAQs based on an enormous amount of manuals.

About dbE., Inc.

Founded in May, 2015, based on its outstanding knowledge and technologies for utilizing data, dbE provides a wide range of products and services that assist businesses in making the most of their data. By combining AI-powered products and data utilization platforms, dbE offers diverse types of DX solutions including “rodanius,” an AI framework product for converting natural language into structured data that can be used for search and analytics, and “PreRobo,” a proprietary data management preparation software equipped with data processing features. Visit us here (Japanese only): https://d-be.co.jp/

*transcosmos is a trademark or registered trademark of transcosmos inc. In Japan and other countries.

*Other company names and product or services names used here are trademarks or registered trademarks of respective companies.

About transcosmos inc.

transcosmos launched its operations in 1966. Since then, we have combined superior “people” with up-to-date “technology” to enhance the competitive strength of our clients by providing them with superior and valuable services. transcosmos currently offers services that support clients’ business processes focusing on both sales expansion and cost optimization through our 168 bases across 30 countries/regions with a focus on Asia, while continuously pursuing Operational Excellence. Furthermore, following the expansion of e-commerce market on the global scale, transcosmos provides a comprehensive One-Stop Global E-Commerce services to deliver our clients’ excellent products and services in 48 countries/regions around the globe. transcosmos aims to be the “Global Digital Transformation Partner” of our clients, supporting the clients’ transformation by leveraging digital technology, responding to the ever-changing business environment.

https://www.trans-cosmos.co.jp/english/

Share article on social media or email:

AESKU.GROUP Submits first Quantitative SARS-CoV-2 antibody test for EUA


SARS-CoV-2 Antigens

Quantitative antibody tests are the primary tool clinicians and researchers use to measure our immune response to both infections and vaccines.

Shortly after infection with SARS-CoV-2, the virus that causes COVID-19, our immune system reacts with IgM and/or IgA antibodies. Once the virus is detected and attacked, the body produces specific IgG to eliminate the virus and maintain some level of protection against future exposure to SARS-CoV-2. Vaccines similarly work by teaching the immune system to make antibodies to protect against specific pathogens. Quantitative antibody tests are the primary tool clinicians and researchers use to measure our immune response to both infections and vaccines.

Antibody measurement requires carefully sifting through the many potential targets and selecting those most immunogenic and unique for the pathogen of interest. Immunogenicity is important because higher levels of antibodies help improve differentiation between positive and negative samples, improving sensitivity. Finding specific proteins reduces the risk of cross-reaction with antibodies to other pathogens, improving specificity. For a SARS-CoV-2 antibody test, the two most established targets are the nucleocapsid protein (NP) and the spike protein (S1).

NP has been demonstrated to be the most sensitive antibody target so NP antibody tests might support earlier identification, but the protein is highly conserved in the coronavirus family, increasing the risk of cross-reaction with non-specific antibodies. Anti-NP antibodies have also not been demonstrated to have a neutralizing effect, so their measurement may not be appropriate to help assess immunity.

S1 has been demonstrated to be highly specific for the SARS-CoV-2 virus lowering the risk of cross-reactions with antibodies against other members of the coronavirus family. S1 contains the receptor-binding domain (RBD) so antibodies against it may be neutralizing.

Additional information about SARS-CoV-2 antibody testing with NP and S1 proteins can be found here.

AESKU.Diagnostics will offer six different SARS-CoV-2 antibody assays, AESKULISA® SARS-CoV-2 NP IgM/ IgA / IgG and AESKULISA® SARS-CoV-2 S1 IgM/ IgA / IgG. IgG and IgM SARS-CoV-2 antibody assays qualify for EUA FDA submission, but IgA assays currently do not.

At a glance:

Advantages of the AESKULISA® SARS-CoV-2 immunoassays at a glance:

  • First quantitative test in the market
  • Room Temperature incubation
  • Easy to automate, optimized for use with any ELISA platform
  • Breakaway wells allow customizable panels
  • Assay Protocol Files available
  • Common reagents
  • Optimized incubation (30 min, 30 min, 30 min)
  • Nucleocapsid Protein IgA / IgG/ IgM


or

  • Spike-Protein S1 IgA / IgG/ IgM

Submission number:EUA201942

ABOUT AESKU

AESKU.GROUP is headquartered in Wendelsheim, Germany and is made up of the following divisions: AESKU.DIAGNOSTICS, AESKU.THERAPY (Autoimmune Therapies), AESKU.SYSTEMS (Lab Automation), AESKU.INC (N. American headquarters in Oakland, CA), AESKU.NY (IFA Manufacturing and Research in Buffalo, NY).

Besides its own outstanding commitment to research and development, AESKU.GROUP initiated and supports the AESKU.KIPP INSTITUTE, an independent non-profit organization, primarily active in basic research and interdisciplinary knowledge transfer in autoimmunity.

Share article on social media or email:

Laurence Fishburne’s “In Depth Series” Experts Explore The Use of Drones in Delivering Vital Items To Consumers


News Image

Drones are a unique development in the world of technology, and innovators are using that technology to make life more efficient and safer.

“King of New York (1990)” actor Laurence Fishburne is putting his talents to work as host of television’s “In Depth Series” with Laurence Fishburne. The show covers a wide array of subjects to inform its viewers about events taking place across the country. The show will take a dip into advances in technology and how drone technology is helping to make essential deliveries.

Drones have been used for years to capture aerial footage for movies, TV shows, and commercials, but now they are being used to make deliveries like medication. Previously they have been used to deliver food aid and medical supplies to areas hit by natural disasters, and now experts see how they can be used to transport items like medicine during the current COVID-19 pandemic. Using drones to deliver medicine would minimize human contact, which could help the spread of the Coronavirus.

In theory, smaller indoor drones could also find use in hospitals or nursing homes. These drones could aid in the deliverance of medicine to the bedside of patients, which could help to minimize potential infection of contagious illnesses and help keep medical costs down by lessening staff.

Drones are a unique development in the world of technology, and innovators are using that technology to make life more efficient and safer. More details about the use of drones in the world of healthcare will be in the new “In Depth Series” episode.

“In Depth Series” with Laurence Fishburne is carefully reviewed before broadcast. The educational TV show has accepted multiple Tellys for its efforts.

Share article on social media or email: